CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Grant or award SVP, General Counsel&Secretary acquired 9,167 shares (grant or award)
- 4 Grant or award EVP, CFO & Treasurer acquired 13,333 shares (grant or award)
- 4 Grant or award President and CEO acquired 42,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 4,114 shares at $0.82 ($3,373)
- 4 Open-market sale President and CEO sold 3,622 shares at $0.79 ($2,861)
- 4 Open-market sale President and CEO sold 3,606 shares at $0.92 ($3,319)
- 4 Open-market sale President and CEO sold 3,589 shares at $1.27 ($4,558)
- 4 Open-market buy Director bought 41,140 shares at $1.22 ($49,985)
- 4 Open-market sale President and CEO sold 3,622 shares at an average $1.33 ($4,817)
- 4 Open-market sale EVP, CFO & Treasurer sold 6,913 shares at $1.33 ($9,203)
- 4 Open-market sale SVP, General Counsel&Secretary sold 3,888 shares at $1.33 ($5,176)
- 4 Open-market sale EVP & Chief Commercial Officer sold 7,415 shares at $1.33 ($9,872)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President and CEO sold 3,722 shares at $1.72 ($6,402)
- 4 Planned sale EVP, Chief Development Officer sold 2,845 shares at $1.70 ($4,837)
- 4 Planned sale President and CEO sold 3,538 shares at $1.72 ($6,085)
- 4 Planned sale EVP & Chief Commercial Officer sold 1,839 shares at $2.35 ($4,322)
- 4 Planned sale President and CEO sold 3,536 shares at $2.24 ($7,922)
- 4 Planned sale EVP, CFO & Treasurer sold 631 shares at $2.22 ($1,401)
Page 7 of 31 · 601 filings